Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AHA on NSAID use

This article was originally published in The Tan Sheet

Executive Summary

"Many doctors should change the way they prescribe pain relievers for chronic pain in patients with or at risk for heart disease," the American Heart Association says in a Feb. 26 news release. The release announces a Scientific Statement appearing in the journal Circulation Feb. 27, which advises physicians to prescribe drugs only if non-pharmacologic treatments are unsuccessful. "When acetaminophen, aspirin and perhaps even narcotic medications are not effective ... it may be reasonable to consider an NSAID as the next step," Elliot M. Antman, M.D., Harvard Medical School and Brigham and Women's Hospital, et al., conclude. "If symptoms are not adequately controlled by a nonselective NSAID, subsequent steps involve prescription of drugs with increasing degrees of COX-2 inhibitory activity, ultimately concluding with the COX-2 selective NSAIDs." The authors say naproxen "appears to be the preferred choice" in terms of NSAID treatments, but note that "relatively few" studies have been conducted on the drug...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS100266

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel